ABVC BioPharma Inc. (ABVC)
NASDAQ · Healthcare
ABVC BioPharma Inc. Total Liabilities 2010–2025
ABVC BioPharma Inc. annual total liabilities history from 2015 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- ABVC BioPharma Inc. total liabilities as of December 31, 2025: 7.8M, a 13.92% increase year-over-year.
- ABVC BioPharma Inc. total liabilities for 2025 were 7.8M, a 13.92% increase from 2024.
- ABVC BioPharma Inc. total liabilities for 2024 were 6.8M, a 4.36% increase from 2023.
- ABVC BioPharma Inc. total liabilities for 2023 were 6.5M, a 2.96% increase from 2022.
- ABVC BioPharma Inc. total liabilities for 2022 were 6.3M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| ABVC BioPharma Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $8 |
| 2024 | $7 |
| 2023 | $7 |
| 2022 | $6 |
| 2021 | $5 |
| 2020 | $9 |
| 2019 | $7 |
| 2018 | $11 |
| 2015 | $0 |
ABVC BioPharma Inc. Total Liabilities — FAQ
ABVC BioPharma Inc. (ABVC) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABVC's total liabilities history?
The chart and table above show ABVC BioPharma Inc.'s total liabilities by year and by quarter, including the growth rate.